XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income $ 17,938 $ 41,654
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 19,572 16,694
Impairment charge - leased assets 7,902 0
Bad debt expense 4,024 3,420
Equity-based compensation expense 8,347 4,860
Deferred income tax expense 1,889 3,630
Fair value adjustments to contingent consideration (105) 330
Other, net 209 1,193
Changes in operating assets and liabilities (16,305) (16,594)
Net cash provided by operating activities 43,471 55,187
Cash flows from investing activities:    
Purchases of property, equipment and capitalization of software (4,575) (10,093)
Acquisitions, net of cash acquired of $867k and $, respectively (10,627) 0
Restricted cash acquired with the Marketing Funds acquisition 0 28,495
Other 0 (1,200)
Net cash (used in) provided by investing activities (15,202) 17,202
Cash flows from financing activities:    
Payments on debt (1,986) (1,964)
Distributions paid to non-controlling unitholders (10,566) (11,460)
Dividends and dividend equivalents paid to Class A common stockholders (12,250) (11,298)
Payments related to tax withholding for share-based compensation (2,268) (836)
Net cash used in financing activities (27,070) (25,558)
Effect of exchange rate changes on cash (30) 76
Net increase in cash, cash equivalents and restricted cash 1,169 46,907
Cash, cash equivalents and restricted cash, beginning of year 103,601 59,974
Cash, cash equivalents and restricted cash, end of period 104,770 106,881
Supplemental disclosures of cash flow information:    
Cash paid for interest 6,638 9,004
Net cash paid for income taxes 3,963 6,032
Payments pursuant to tax receivable agreements 0 2,854
Schedule of non-cash investing activities:    
Class A shares issued as consideration for acquisitions $ 8,800 $ 0